Delhi HC grants relief to Sun Pharma in trademark suit for drug Labebet

The suit filed by Sun Pharma sought a decree of permanent injunction to restrain the defendants from manufacturing, marketing, selling, offering for sale, advertising, directly or indirectly dealing in medicinal preparations under the mark Lulibet

from Livemint - News https://ift.tt/3eTjYY5
https://ift.tt/eA8V8J